In patients treated with EGFR inhibitors, EGFR expression was diminished both in the tumor as well as skin samples, which demonstrates the parallel and simultaneous biological effects of these drugs, making it possible to determine the stage of blockade of EGFR with a skin biopsy analysis.18, 19, 20. This evidence concerns the gene EGFR and neoplasm.